Invention Grant
US09217042B2 Method of reducing MACE in diabetic patients subsequent to stent placement
有权
在支架放置后减少糖尿病患者的MACE的方法
- Patent Title: Method of reducing MACE in diabetic patients subsequent to stent placement
- Patent Title (中): 在支架放置后减少糖尿病患者的MACE的方法
-
Application No.: US13658699Application Date: 2012-10-23
-
Publication No.: US09217042B2Publication Date: 2015-12-22
- Inventor: Paul M. Consigny
- Applicant: Abbott Cardiovascular Systems Inc.
- Applicant Address: US CA Santa Clara
- Assignee: ABBOTT CARDIOVASCULAR SYSTEMS INC.
- Current Assignee: ABBOTT CARDIOVASCULAR SYSTEMS INC.
- Current Assignee Address: US CA Santa Clara
- Agency: Squire Patton Boggs (US) LLP
- Main IPC: A61F2/06
- IPC: A61F2/06 ; C07K16/46 ; A61L27/50 ; A61K39/00
Abstract:
This invention relates to the use of dual variable domain antibodies to locate naturally-occurring beneficial agents or therapeutic agents at a region of stent implantation in diabetic patients who have undergone stent implantation.
Public/Granted literature
- US20140114401A1 Method Of Reducing MACE In Diabetic Patients Subsequent To Stent Placement Public/Granted day:2014-04-24
Information query
IPC分类:
